Want to join the conversation?
$OREX 2Q15 PR: Revenue was $5.2MM, including $3.1MM in royalties earned on US net sales of Contrave of $16MM recorded by Takeda Pharmaceuticals. Net loss was $22.5MM, or $0.18 per share vs. net loss of $24.5MM, or $0.21 per share for 2Q14.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!